Zivana Tezak
Chief, Molecular Genetics Branch, Division of Molecular Genetics and Pathology @FDA
Signup · Get unlimited contacts
WORK HISTORY
Chief, Molecular Genetics Branch, Division of Molecular Genetics and Pathology @FDA
MD, US
EDUCATION
Florida State University
Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology
University of Zagreb / Sveučilište u Zagrebu
M.Sc., Biochemistry
ABOUT ZIVANA TEZAK
Zivana Tezak, Ph.D, Chief, Molecular Genetics Branch, Division of Molecular Genetics and Pathology in the Office of In Vitro Diagnostic Device (IVD) Evaluation and Safety (OHT7), at the Center for Devices and Radiological Health (CDRH), Food and Drug Administration (FDA). Prior to her role as a Branch Chief, she was Associate Director for Science and Technology, Personalized Medicine, in the OIR/CDRH/FDA. Prior to joining the FDA in 2004, Dr. Tezak worked in biotechnology industry, holding research and development positions in a bioinformatics and array developer company. After receiving her Ph.D, Dr. Tezak was a research fellow at the University of Pittsburgh Medical Center and Children’s National Medical Center, Research Center for Genetic Medicine, working on neuromuscular disorders, human genetics, gene therapy and high-throughput screening technologies. In her current position, Dr. Tezak has been leading efforts to develop flexible regulatory policies for novel technology based clinical diagnostic tests in order to enable their smoother translation into the clinic.Sample coverage:Bio-IT World, precisionFDA Announces Winners of Consistency ChallengeFast Company, Genetic Testing Needs To Get Better, And The FDA Wants To HelpBioCentury Innovations, Nine challenges FDA wants scientists to solve for NGS-based diagnostics
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.